Investing.com - Sunshine Biopharma (NASDAQ: SBFM) reported third quarter EPS of $-0.0400, $0.02 better than the analyst estimate of $-0.0600. Revenue for the quarter came in at $5.96M versus the consensus estimate of $6M.
Sunshine Biopharma's stock price closed at $0.2500. It is down -47.0300% in the last 3 months and down -68.2900% in the last 12 months.
Sunshine Biopharma saw positive EPS revisions and negative EPS revisions in the last 90 days. See Sunshine Biopharma's stock price’s past reactions to earnings here.
According to InvestingPro, Sunshine Biopharma's Financial Health score is "fair performance".
Check out Sunshine Biopharma's recent earnings performance, and Sunshine Biopharma's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar